Trial intelligence / Profile preview

Topical glucosamine for plaque psoriasis

IRCT20200817048439N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in plaque psoriasis comparing Topical glucosamine side with Placebo side (2 arms). Primary endpoint: Modified PASI score change. Started May 2016; status: completed.

02

Drugs

glucosamine sulphate
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on IRCT20200817048439N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200817048439N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call